Awards & Advancement

VentiRx Pharmaceuticals appoints James Kyle Bryan as CMO

Thursday, April 25, 2013 08:00 AM

VentiRx Pharmaceuticals, a clinical stage biopharmaceutical company focused on novel Toll-like receptor 8 (TLR8) immunotherapies for the treatment of cancer, respiratory and inflammatory diseases, has appointed James Kyle Bryan, M.D., as chief medical officer. 

More... »

Oramed appoints Hexter as COO, vice president of business development

Monday, April 22, 2013 08:00 AM

Oramed Pharmaeuticals, a developer of oral drug delivery systems, has appointed Joshua Hexter as chief operating officer and vice president of business development.

More... »

Orexigen CEO Michael Narachi elected to PhRMA board of directors

Monday, April 22, 2013 08:00 AM

Michael Narachi, president and CEO of Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity, has been named to the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA). Narachi will serve as a director for a term of two years.

More... »

Lynn Kramer appointed chief clinical officer of Eisai Product Creation Systems

Friday, April 12, 2013 02:13 PM

Eisai has appointed Lynn Kramer, MD, to the newly created position of chief clinical officer of Eisai Product Creation Systems.

More... »

BMS appoints Francis Cuss as executive vice president, CSO

Monday, April 8, 2013 03:00 PM

Bristol-Myers Squibb, a global biopharmaceutical company, has appointed Francis Cuss, MB, BChir, FRCP, as executive vice president and chief scientific officer, effective July 1 after Elliott Sigal, M.D., Ph.D., retires.

More... »

EntreMed announces changes to board of directors, CEO appointment

Friday, April 5, 2013 12:05 PM

The board of directors of EntreMed, a clinical-stage pharmaceutical company focused on cancer, has appointed two new individuals as directors. Joining the board are James Huang and Y. Alexander Wu, Ph.D.

More... »

Quintiles digital properties win two Web Marketing Assoc. awards

Thursday, April 4, 2013 08:00 AM

Quintiles, a provider of biopharmaceutical development and commercial outsourcing services, has received further recognition for the company’s digital communications with two “Internet Advertising Competition” (IAC) awards: one for its corporate website, Quintiles.com, and one for its patient education site, ClinicalResearch.com.

More... »

SynteractHCR hires Bill Pierce and Richard Paul

Thursday, April 4, 2013 08:00 AM

SynteractHCR, a full-service CRO, has hired two new senior executives to support the company's growth on a global scale following its recent merger. SynteractHCR has appointed Bill Pierce as chief information officer and Richard Paul as chief medical officer and vice president medical/regulatory affairs.

More... »

Chiltern promotes Stuart McGuire and Jim Szymeczek

Thursday, March 28, 2013 08:00 AM

Chiltern International, a global contract CRO, has promoted Stuart McGuire to the position of vice president of global business development, and Jim Szymeczek to the position of vice president of global information technology and systems.

More... »

PPD appoints Jay Dixon as vice president, global quality and compliance

Tuesday, March 26, 2013 08:00 AM

Pharmaceutical Product Development (PPD), a global CRO, has appointed Jay Dixon as senior vice president, global quality and compliance. Dixon’s expertise will enhance PPD’s ability to deliver industry-leading drug development services and high-quality data across the full spectrum of the research and development life cycle.

More... »